These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 22116094)

  • 1. Defibrotide interferes with several steps of the coagulation-inflammation cycle and exhibits therapeutic potential to treat severe malaria.
    Francischetti IM; Oliveira CJ; Ostera GR; Yager SB; Debierre-Grockiego F; Carregaro V; Jaramillo-Gutierrez G; Hume JC; Jiang L; Moretz SE; Lin CK; Ribeiro JM; Long CA; Vickers BK; Schwarz RT; Seydel KB; Iacobelli M; Ackerman HC; Srinivasan P; Gomes RB; Wang X; Monteiro RQ; Kotsyfakis M; Sá-Nunes A; Waisberg M
    Arterioscler Thromb Vasc Biol; 2012 Mar; 32(3):786-98. PubMed ID: 22116094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defibrotide: a Swiss Army knife intervention in the battle against cerebral malaria.
    Moore JM; Avery JW
    Arterioscler Thromb Vasc Biol; 2012 Mar; 32(3):541-4. PubMed ID: 22345588
    [No Abstract]   [Full Text] [Related]  

  • 3. Investigation of hydrogen sulfide gas as a treatment against P. falciparum, murine cerebral malaria, and the importance of thiolation state in the development of cerebral malaria.
    DellaValle B; Staalsoe T; Kurtzhals JA; Hempel C
    PLoS One; 2013; 8(3):e59271. PubMed ID: 23555646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasmodium falciparum-infected erythrocytes induce tissue factor expression in endothelial cells and support the assembly of multimolecular coagulation complexes.
    Francischetti IM; Seydel KB; Monteiro RQ; Whitten RO; Erexson CR; Noronha AL; Ostera GR; Kamiza SB; Molyneux ME; Ward JM; Taylor TE
    J Thromb Haemost; 2007 Jan; 5(1):155-65. PubMed ID: 17002660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eugenol disrupts Plasmodium falciparum intracellular development during the erythrocytic cycle and protects against cerebral malaria.
    Pontes KAO; Silva LS; Santos EC; Pinheiro AS; Teixeira DE; Peruchetti DB; Silva-Aguiar RP; Wendt CHC; Miranda KR; Coelho-de-Souza AN; Leal-Cardoso JH; Caruso-Neves C; Pinheiro AAS
    Biochim Biophys Acta Gen Subj; 2021 Mar; 1865(3):129813. PubMed ID: 33321150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Small molecule-based inhibition of MEK1/2 proteins dampens inflammatory responses to malaria, reduces parasite load, and mitigates pathogenic outcomes.
    Wu X; Dayanand KK; Thylur RP; Norbury CC; Gowda DC
    J Biol Chem; 2017 Aug; 292(33):13615-13634. PubMed ID: 28679535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The antimicrobial molecule trappin-2/elafin has anti-parasitic properties and is protective in vivo in a murine model of cerebral malaria.
    Roussilhon C; Bang G; Bastaert F; Solhonne B; Garcia-Verdugo I; Peronet R; Druilhe P; Sakuntabhai A; Mecheri S; Sallenave JM
    Sci Rep; 2017 Feb; 7():42243. PubMed ID: 28181563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of experimental cerebral malaria by Flt3 ligand during infection with Plasmodium berghei ANKA.
    Tamura T; Kimura K; Yuda M; Yui K
    Infect Immun; 2011 Oct; 79(10):3947-56. PubMed ID: 21807908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of murine cerebral malaria by artemisone in combination with conventional antimalarial drugs: antiplasmodial effects and immune responses.
    Guiguemde WA; Hunt NH; Guo J; Marciano A; Haynes RK; Clark J; Guy RK; Golenser J
    Antimicrob Agents Chemother; 2014 Aug; 58(8):4745-54. PubMed ID: 24913162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human C1-Inhibitor Suppresses Malaria Parasite Invasion and Cytoadhesion via Binding to Parasite Glycosylphosphatidylinositol and Host Cell Receptors.
    Mejia P; Diez-Silva M; Kamena F; Lu F; Fernandes SM; Seeberger PH; Davis AE; Mitchell JR
    J Infect Dis; 2016 Jan; 213(1):80-9. PubMed ID: 26347576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ethanolic extract of the fungus Trichoderma stromaticum decreases inflammation and ameliorates experimental cerebral malaria in C57BL/6 mice.
    Cariaco Y; Lima WR; Sousa R; Nascimento LAC; Briceño MP; Fotoran WL; Wunderlich G; Dos Santos JL; Silva NM
    Sci Rep; 2018 Jan; 8(1):1547. PubMed ID: 29367729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. L-arginine exacerbates experimental cerebral malaria by enhancing pro-inflammatory responses.
    Xu H; Feng Y; Chen G; Zhu X; Pang W; Du Y; Wang Q; Qi Z; Cao Y
    Tohoku J Exp Med; 2015 May; 236(1):21-31. PubMed ID: 25925198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiplasmodial, anti-complement and anti-inflammatory in vitro effects of Biophytum umbraculum Welw. traditionally used against cerebral malaria in Mali.
    Austarheim I; Pham AT; Nguyen C; Zou YF; Diallo D; Malterud KE; Wangensteen H
    J Ethnopharmacol; 2016 Aug; 190():159-64. PubMed ID: 27260410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting Toll-like receptors by chloroquine protects mice from experimental cerebral malaria.
    Zhu X; Pan Y; Li Y; Jiang Y; Shang H; Gowda DC; Cui L; Cao Y
    Int Immunopharmacol; 2012 Aug; 13(4):392-7. PubMed ID: 22659438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Virus Hosted in Malaria-Infected Blood Protects against T Cell-Mediated Inflammatory Diseases by Impairing DC Function in a Type I IFN-Dependent Manner.
    Hassan A; Wlodarczyk MF; Benamar M; Bassot E; Salvioni A; Kassem S; Berry A; Saoudi A; Blanchard N
    mBio; 2020 Apr; 11(2):. PubMed ID: 32265335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tempol, an intracellular antioxidant, inhibits tissue factor expression, attenuates dendritic cell function, and is partially protective in a murine model of cerebral malaria.
    Francischetti IM; Gordon E; Bizzarro B; Gera N; Andrade BB; Oliveira F; Ma D; Assumpção TC; Ribeiro JM; Pena M; Qi CF; Diouf A; Moretz SE; Long CA; Ackerman HC; Pierce SK; Sá-Nunes A; Waisberg M
    PLoS One; 2014; 9(2):e87140. PubMed ID: 24586264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rocaglates as dual-targeting agents for experimental cerebral malaria.
    Langlais D; Cencic R; Moradin N; Kennedy JM; Ayi K; Brown LE; Crandall I; Tarry MJ; Schmeing M; Kain KC; Porco JA; Pelletier J; Gros P
    Proc Natl Acad Sci U S A; 2018 Mar; 115(10):E2366-E2375. PubMed ID: 29463745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The T-Cell Inhibitory Molecule Butyrophilin-Like 2 Is Up-regulated in Mild Plasmodium falciparum Infection and Is Protective During Experimental Cerebral Malaria.
    Subramaniam KS; Spaulding E; Ivan E; Mutimura E; Kim RS; Liu X; Dong C; Feintuch CM; Zhang X; Anastos K; Lauvau G; Daily JP
    J Infect Dis; 2015 Oct; 212(8):1322-31. PubMed ID: 25883389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Terminalia albida treatment improves survival in experimental cerebral malaria through reactive oxygen species scavenging and anti-inflammatory properties.
    Camara A; Haddad M; Reybier K; Traoré MS; Baldé MA; Royo J; Baldé AO; Batigne P; Haidara M; Baldé ES; Coste A; Baldé AM; Aubouy A
    Malar J; 2019 Dec; 18(1):431. PubMed ID: 31852507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of proinflammatory responses in macrophages by the glycosylphosphatidylinositols of Plasmodium falciparum: the requirement of extracellular signal-regulated kinase, p38, c-Jun N-terminal kinase and NF-kappaB pathways for the expression of proinflammatory cytokines and nitric oxide.
    Zhu J; Krishnegowda G; Gowda DC
    J Biol Chem; 2005 Mar; 280(9):8617-27. PubMed ID: 15611045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.